Wegman Toby 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Sep 10, 2019
Insider Transaction Report
Form 4
Wegman Toby
Director10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2019-09-09$55.23/sh−1,100$60,753→ 943,973 total(indirect: See footnote) - Sale
Common Stock, $0.001 par value
2019-09-10$55.16/sh−8,900$490,924→ 935,073 total(indirect: See footnote)
Holdings
- 1,890
Common Stock, $0.001 par value
Footnotes (3)
- [F1]The selling price of $55.23 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $55.20 to $55.35. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The selling price of $55.16 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $55.00 to $55.44. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]These shares are held in trust on behalf of the reporting person. The reporting person is the trustee of the trust. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.